[Effects of morphazinamide administered alone or in association in treatment of pulmonary tuberculosis. Observations on 126 treated cases].
D000995:Antitubercular Agents / Q000009:adverse effects* / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D006801:Humans; D011719:Pyrazines / Q000627:therapeutic use; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy*
D000995:Antitubercular Agents; D011719:Pyrazines
Effetti della morfazinamide somministrata da sola o in associazione nella cura della tubercolosi polmonare. Osservazioni su 126 casi trattati.